Unbound MEDLINE

A preliminary trial: double-blind comparison of nefazodone, bupropion-SR, and placebo in the treatment of cannabis dependence. The American journal on addictions / American Academy of Psychiatrists in Alcoholism and Addictions [Am J Addict] Journal article

 
TitleA preliminary trial: double-blind comparison of nefazodone, bupropion-SR, and placebo in the treatment of cannabis dependence.
Author(s)Carpenter KM, McDowell D, Brooks DJ, Cheng WY, Levin FR 
InstitutionDivision on Substance Abuse, New York State Psychiatric Institute, New York, USA.
SourceAm J Addict 2009 Jan-Feb; 18(1):53-64.
MeSHAdult
Antidepressive Agents, Second-Generation
Bupropion
Delayed-Action Preparations
Double-Blind Method
Female
Humans
Male
Marijuana Abuse
Outcome Assessment (Health Care)
Placebos
Severity of Illness Index
Substance Withdrawal Syndrome
Triazoles
AbstractThe present study investigated the efficacy of nefazodone and bupropion-sustained release for treating cannabis dependence. A double-blind, placebo-controlled, piggy back design was employed to assess if nefazodone and bupropion-sustained release increased the probability of abstinence from cannabis and reduced the severity of cannabis dependence and cannabis withdrawal symptoms during a 13-week outpatient treatment program. One-hundred and six participants (Mean = 32 years; females n = 25) were randomized to one of three medication conditions (nefazodone, bupropion-sustained release, or placebo) and participated in a weekly, individually based coping skills therapy program. Results indicated an increased probability of achieving abstinence over the course of treatment and a decrease in the severity of cannabis dependence and the withdrawal symptom of irritability. There were no significant effects demonstrated for nefazodone and bupropion-sustained release on cannabis use or cannabis withdrawal symptoms. The results indicate nefazodone and bupropion-sustained release may have limited efficacy in treating cannabis dependence.
Languageeng
Pub Type(s)Journal Article
Randomized Controlled Trial
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
PubMed ID19219666
  
Advertise on this site.